Review Article
Upper Tract Urothelial Carcinomas in Patients with Chronic Kidney Disease: Relationship with Diagnostic Challenge
Table 2
Detection rates for urothelial carcinomas and upper tract urothelial carcinomas in dialysis patients using urological and imaging methods.
| Patients | Test | Positive result ()/total number () | Detection rate (%) | Reference |
| Urothelial carcinoma |
Urine cytology | 7/24 | 29.2% | Wang et al. [17] | 2/6 | 33.3% | Chen et al. [23] | Retrograde pyelography | 21/28 | 75.0% | Wang et al. [17] | Cystoscopy | 67/80 | 80.7% | Wang et al. [17] | Computed tomography | 42/51 | 82.4% | Wang et al. [17] | Magnetic resonance imaging | 37/39 | 94.9% | Wang et al. [17] | Cystoscopy and/or retrograde pyelography | 14/16 | 87.5% | Chen et al. [23] | Computed tomography and endoscopy | 16/16 | 100.0% | Satoh et al. [28] |
| Upper tract urothelial carcinoma | Urine cytology | 0/10 | 0.0% | Satoh et al. [28] | Retrograde pyelography | 6/7 | 85.7% | Chen et al. [23] | Computed tomography and endoscopy | 10/10 | 100.0% | Satoh et al. [28] |
|
|
: number of patients with positive results in each diagnostic test. : number of patients who underwent each diagnostic test.
|